Evidence map›Paper›PMID 42547441›Full record

ArticleZhonghua shao shang yu chuang mian xiu fu za zhi2026

[Bidirectional two-sample MR analysis of causal relationships between human inflammatory proteins and HS and keloids].

S S Wang, K Xiao, H T Xiao, D W Han, J Zhang, L Wang, Y C Li

Abstract readEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua shao shang yu chuang mian xiu fu za zhi, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

S S WangDepartment of Burns, Zhengzhou First People's Hospital, Zhengzhou 450004, China.
K XiaoBasic Medical College, Guangxi Medical University, Nanning 530021, China.
H T XiaoDepartment of Burns, Zhengzhou First People's Hospital, Zhengzhou 450004, China.
D W HanDepartment of Burns, Zhengzhou First People's Hospital, Zhengzhou 450004, China.
J ZhangDepartment of Burns, Zhengzhou First People's Hospital, Zhengzhou 450004, China.
L WangDepartment of Burns, Zhengzhou First People's Hospital, Zhengzhou 450004, China.
Y C LiDepartment of Burns, Zhengzhou First People's Hospital, Zhengzhou 450004, China.

Funding

Henan Provincial Key Medical Science and Technology Research Program LHGJ20191002, LHGJ20220809National Construction Program for Key Clinical Specialties 2023-70Zhengzhou City Guidance Program for Scientific and Technological Innovation in the Medical and Health Field 2025YLZDJH086
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cicatrix, HypertrophicKeloidFibroblast Growth Factor-23Fibroblast Growth FactorsGenome-Wide Association StudyHumansLeukemia Inhibitory FactorMendelian Randomization AnalysisFGF23 protein, humanFibroblast Growth Factor-23Fibroblast Growth FactorsLeukemia Inhibitory FactorLIF protein, human

Identifiers

PMID42547441
PMCPMC13416976

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.